Japan defines functional categories for reimbursement based on a device’s clinical purpose, technological characteristics, and therapeutic application. These categories group devices with similar functions to standardize evaluation and pricing under the NHI system. New or innovative devices may require unique categories, subject to Chuikyo’s assessment of their safety, efficacy, and cost-effectiveness.
